Dexcom (DXCM) Accumulated Depreciation & Amortization (2010 - 2026)

Dexcom (DXCM) has 17 years of Accumulated Depreciation & Amortization data on file, last reported at $11.7 million in Q1 2026.

• Quarterly Accumulated Depreciation & Amortization rose 27.17% year-over-year to $11.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.7 million (up 27.17% YoY) and the FY2025 annual result came in at $39.5 million, down 1.0% from the prior year.
• Accumulated Depreciation & Amortization fell to $11.7 million in Q1 2026 per DXCM's latest filing, from $39.5 million in the prior quarter.
• Across five years, Accumulated Depreciation & Amortization topped out at $466.3 million in Q3 2023 and bottomed at $9.2 million in Q1 2025.
• The 5-year median for Accumulated Depreciation & Amortization is $39.5 million (2025), against an average of $84.8 million.
• The widest annual swing landed in 2023, when Accumulated Depreciation & Amortization surged 432.71%; it then plunged 97.81% in 2024.
• Tracing DXCM's Accumulated Depreciation & Amortization over 5 years: stood at $46.7 million in 2022, then slipped by 10.28% to $41.9 million in 2023, then dropped by 4.77% to $39.9 million in 2024, then decreased by 1.0% to $39.5 million in 2025, then tumbled by 70.38% to $11.7 million in 2026.
• Per Business Quant, the three latest DXCM Accumulated Depreciation & Amortization figures stand at $11.7 million (Q1 2026), $39.5 million (Q4 2025), and $9.6 million (Q3 2025).

Peer Comparison